Chahin Pach AI
About Chahin Pach AI
Chahin Pach AI is the Director of Medical Imaging at Bristol Myers Squibb, specializing in MRI, CT, and PET imaging for CNS diseases, oncology, and cardiovascular diseases.
Title and Current Role
Chahin Pach AI is the Director of Medical Imaging at Bristol Myers Squibb, based in Princeton, New Jersey, United States. He started this role in October 2021. His responsibilities include overseeing medical imaging in various clinical trials and ensuring the accurate quantification of MRI, CT, and PET imaging data.
Professional Experience at Bristol Myers Squibb
Chahin Pach AI has a deep history with Bristol Myers Squibb. Prior to his current role as Director - Medical Imaging, he served as the Associate Director - Medical Imaging from 2019 to 2021 in Greater New York City Area. His roles at BMS encompass significant involvement in clinical trial imaging and leading imaging efforts for CNS diseases, oncology, and cardiovascular diseases.
Previous Roles in Medical Imaging
Before his tenure at Bristol Myers Squibb, Chahin Pach AI held key positions in several organizations. He was the Director of the Imaging Core Laboratory at Medpace from 2016 to 2018 in Lyon, France. He served as Vice President - Executive Director at BioClinica from 2007 to 2014, and previously was CEO of Theralys from 2001 to 2007.
Educational Background
Chahin Pach AI has a strong academic foundation. He studied Electrical Engineering and earned his Ph.D. at INSA Lyon - Institut National des Sciences Appliquées de Lyon, completing his studies from 1992 to 2000. He further specialized in Medical Imaging at Harvard Medical School from 1997 to 1998. Additionally, he completed an Entrepreneurship Program at emlyon business school in 2000.
Expertise in Medical Imaging
Chahin Pach AI is an expert in medical imaging with a specific focus on quantification techniques for MRI, CT, and PET imaging. His specialization includes medical imaging for CNS diseases, oncology, and cardiovascular diseases. He has extensive experience in both academic and industry settings, contributing significantly to clinical trials related to medical imaging.